TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34159708

Group type: EXPERIMENTAL
Intervention: Dulaglutide 3.0 mg
Number of subjects: 1842

Group type: EXPERIMENTAL
Intervention: Dulaglutide 4.5 mg
Number of subjects: 1842

Group type: COMPARATOR
Intervention: Dulaglutide 1.5 mg
Number of subjects: 1842

Group type: EXPERIMENTAL
Intervention: Composite endpoint (HbA1c < 7% with no weight gain and no documented symptomatic or severe hypoglycaemia)
Number of subjects: 1842

Group type: EXPERIMENTAL
Intervention: Safety profile
Number of subjects: 1842
Study: 32610647

Group type: EXPERIMENTAL
Intervention: Intermittent Hypoxic Exposure (IHE)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Arginine (2 × 6 g/day) with IHE
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: IHE and Arg/IHE
Number of subjects: 38
Study: 34253099

Group type: EXPERIMENTAL
Intervention: Interventions related to maintaining/improving resident function, providing adequate nurse staffing levels, and improving staff communication skills.
Number of subjects: 536

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 536
Study: 33545090

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Initial viral load
Number of subjects: 314
Study: 35688515

Group type: EXPERIMENTAL
Intervention: Lateral QLB
Number of subjects: 111

Group type: COMPARATOR
Intervention: LPB
Number of subjects: 111
Study: 32586363

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (200 mg tablet every other day for 2 months)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (identical in terms of shape, colour, smell, 200 mg tablet every other day for 2 months)
Number of subjects: 60
Study: 35489606

Group type: EXPERIMENTAL
Intervention: BCG vaccine
Number of subjects: 1511

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1511
Study: 34876630

Group type: EXPERIMENTAL
Intervention: RAM cannula with Cannulaide
Number of subjects: 229

Group type: COMPARATOR
Intervention: Hudson prong
Number of subjects: 229
Study: 89155066

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Chlordiazepoxide and chlorpromazine combination
Number of subjects: 120
Study: 35611641

Group type: EXPERIMENTAL
Intervention: CDS displaying NEWT
Number of subjects: 2682

Group type: COMPARATOR
Intervention: Control (usual care with NEWT accessed at clinician discretion)
Number of subjects: 2682
Study: 34143564

Group type: EXPERIMENTAL
Intervention: Continuous IV sildenafil
Number of subjects: 43

Group type: COMPARATOR
Intervention: Intermittent IV sildenafil
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 43
Study: 32016532

Group type: EXPERIMENTAL
Intervention: Methylnaltrexone
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 32379241

Group type: EXPERIMENTAL
Intervention: Isoinertial training
Number of subjects: 34

Group type: COMPARATOR
Intervention: Cable-resistance training
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both training programs
Number of subjects: 34
Study: 33846472

Group type: EXPERIMENTAL
Intervention: Convolutional Neural Network (CNN) model using brain MRI data
Number of subjects: 221
Study: 34076602

Group type: EXPERIMENTAL
Intervention: Periprocedural myocardial infarction (MI)
Number of subjects: 586

Group type: EXPERIMENTAL
Intervention: Patients with periprocedural MI
Number of subjects: 586

Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 586
Study: 34793989

Group type: EXPERIMENTAL
Intervention: Vegetable intervention (8-week feeding phase with DGA-recommended types and amounts of vegetables)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Attention control group (no vegetables provided, same testing schedule)
Number of subjects: 75
Study: 33434493

Group type: EXPERIMENTAL
Intervention: moPMR‐Egger (multiple outcome probabilistic Mendelian randomization with Egger assumption)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: moPMR‐Egger
Number of subjects: 0
Study: 34420924

Group type: EXPERIMENTAL
Intervention: Smartphone app (Prepit, Ferring B V)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Control group (regular written instructions)
Number of subjects: 173
Study: 32738588

Group type: EXPERIMENTAL
Intervention: Updated version of the Behaviour of Young Novice Drivers Scale (BYNDS)
Number of subjects: 700
Study: 34313502

Group type: EXPERIMENTAL
Intervention: Self-care intervention (N = 52)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Passive control condition (N = 43)
Number of subjects: 95
Study: 32815386

Group type: EXPERIMENTAL
Intervention: Electroacupuncture plus warm needling (EAWN) therapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Waitlist control (no treatment)
Number of subjects: 80
Study: 33175132

Group type: EXPERIMENTAL
Intervention: High-dose (HD) IIV followed by standard dose (SD) vaccine (HD-SD arm)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Standard dose (SD) vaccines (SD-SD arm)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Both HD-SD and SD-SD arms
Number of subjects: 68
Study: 32910434

Group type: EXPERIMENTAL
Intervention: Guselkumab 100 mg every 8 weeks
Number of subjects: 992
Study: 35120040

Group type: EXPERIMENTAL
Intervention: External warming using a forced-air warming blanket for 48 hours, goal temperature 1.5°C above the lowest temperature documented in the previous 24 hours.
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard temperature management (control group).
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: External warming using a forced-air warming blanket for 48 hours.
Number of subjects: 56
Study: 33012264

Group type: EXPERIMENTAL
Intervention: Black participants
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Income mediation
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Difficulty paying monthly bills mediation
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Health literacy mediation
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Education mediation
Number of subjects: 184
Study: 32812033

Group type: EXPERIMENTAL
Intervention: Vitamin A supplemented at 2,200 IU/kg of dietary DM
Number of subjects: 30

Group type: COMPARATOR
Intervention: Vitamin A supplemented at 0 IU/kg of dietary DM (Control)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Vitamin A supplemented at 11,000 IU/kg of dietary DM
Number of subjects: 30
Study: 34728061

Group type: EXPERIMENTAL
Intervention: D-series resolvins (D1, D2, D3, D5), resolvin E1, maresin 1, docosahexaenoic acid, eicosapentaenoic acid, 18-hydroxyeicosapentaenoic acid
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid and 18-hydroxyeicosapentaenoic acid
Number of subjects: 31
Study: 32649760

Group type: EXPERIMENTAL
Intervention: Bolus 30-g dose of LNS
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Divided 3 × 10-g doses of LNS
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (no LNS)
Number of subjects: 26
Study: 33248154

Group type: EXPERIMENTAL
Intervention: Participants instructed about the precise CS‐US contingency before conditioning
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Participants instructed to discover the CS‐US contingency
Number of subjects: 102

Group type: COMPARATOR
Intervention: No contingency instructions provided (Control group)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Contingency reversal instructions
Number of subjects: 102
Study: 36112256

Group type: EXPERIMENTAL
Intervention: LipiFlow® thermal pulsation treatment
Number of subjects: 50

Group type: COMPARATOR
Intervention: Warm compress combined with manual lid massage
Number of subjects: 50
Study: 34649555

Group type: EXPERIMENTAL
Intervention: 30-min mindful breathing session
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 80
Study: 34882106

Group type: EXPERIMENTAL
Intervention: EEG-guided care (SedLine)
Number of subjects: 1560

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1560
Study: 33249611

Group type: EXPERIMENTAL
Intervention: Paula Method exercises
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 64
Study: 33233658

Group type: EXPERIMENTAL
Intervention: Partly fermented infant formula (IF) with postbiotics, 2'‐FL, scGOS/lcFOS, and milk fat
Number of subjects: 215

Group type: COMPARATOR
Intervention: Control group (IF with 0.8 g/100 mL scGOS/lcFOS (9:1))
Number of subjects: 215
Study: 35347362

Group type: EXPERIMENTAL
Intervention: Ultrasound-accelerated catheter-directed thrombolysis (CDT) for acute thrombi
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ultrasound-accelerated catheter-directed thrombolysis (CDT) for subacute thrombi
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ultrasound-accelerated catheter-directed thrombolysis (CDT) for old thrombi
Number of subjects: 56
Study: 34987350

Group type: EXPERIMENTAL
Intervention: Psychosocial occupational therapy combined with anodal tDCS (12 sessions, 20 minutes, 2 mA intensity on the left DLPFC)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 24
Study: 35339987

Group type: EXPERIMENTAL
Intervention: L-arginine (1.66 g, twice a day for 3 weeks)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo (identical aspect, no L-arginine, twice a day for 3 weeks)
Number of subjects: 110
Study: 32641240

Group type: EXPERIMENTAL
Intervention: ADXS-HPV (1 × 10^9 colony-forming units in 250 mL IV over 15 min every 28 days)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: ADXS-HPV
Number of subjects: 50
Study: 34971264

Group type: EXPERIMENTAL
Intervention: Home-based music programme plus standard care (SC)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Home-based reading programme plus standard care (SC)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Home-based music programme plus SC
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Home-based reading programme plus SC
Number of subjects: 130
Study: 32099001

Group type: EXPERIMENTAL
Intervention: Convolutional Neural Networks (CNNs) trained on CT imaging
Number of subjects: 549

Group type: COMPARATOR
Intervention: Experienced radiologists' assessments
Number of subjects: 549
Study: 35137394

Group type: COMPARATOR
Intervention: erenumab 70 mg
Number of subjects: 1532

Group type: COMPARATOR
Intervention: erenumab 140 mg
Number of subjects: 1532
Study: 34856179

Group type: EXPERIMENTAL
Intervention: Sustained provision of multiple self-tests to women at high risk of HIV infection.
Number of subjects: 2090

Group type: COMPARATOR
Intervention: Referral cards for facility-based testing (comparison group).
Number of subjects: 2090
Study: 35813628

Group type: COMPARATOR
Intervention: VED
Number of subjects: 105

Group type: COMPARATOR
Intervention: Li-ESWT
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: VED plus Li-ESWT
Number of subjects: 105
Study: 34106758

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IV thrombolytic treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multimodality imaging
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Advanced neuroimaging
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CT, CTA, MRI, MRA
Number of subjects: 0
Study: 32522031

Group type: EXPERIMENTAL
Intervention: Telemedicine facility
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Self-monitoring of blood glucose (SMBG)
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Glycemic control (HbA1c)
Number of subjects: 3000
Study: 34871782

Group type: EXPERIMENTAL
Intervention: Smartphone-based daily feedback and counseling platform (App group)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Routine lactation counseling and support (control group)
Number of subjects: 197
Study: 32195159

Group type: EXPERIMENTAL
Intervention: Perineal massage with Ostrich oil
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (no perineal massage with Ostrich oil)
Number of subjects: 77
Study: 36052975

Group type: EXPERIMENTAL
Intervention: CT-derived 3D virtual explanation module accessed via smartphone before admission.
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Link recipients (third parties) of the intervention group.
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 62
Study: 33908425

Group type: EXPERIMENTAL
Intervention: Continuous femoral nerve block (NB) with ropivacaine through an NB catheter and a sham saline periarticular injection (PI).
Number of subjects: 74

Group type: COMPARATOR
Intervention: Periarticular injection (PI) of ropivacaine, morphine, ketorolac, and epinephrine, with a sham saline infusion via an NB catheter.
Number of subjects: 74
Study: 35672834

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 511

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 511

Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 511
Study: 32611445

Group type: EXPERIMENTAL
Intervention: Time-lapse imaging (TLI)
Number of subjects: 1575

Group type: EXPERIMENTAL
Intervention: Undisturbed culture
Number of subjects: 1575

Group type: COMPARATOR
Intervention: Current standard methods of embryo incubation and assessment
Number of subjects: 1575
Study: 35657971

Group type: EXPERIMENTAL
Intervention: Environmental control strategies (ECS) plus asthma controller medication titration
Number of subjects: 155

Group type: COMPARATOR
Intervention: Controller medication titration alone
Number of subjects: 155
Study: 33427618

Group type: EXPERIMENTAL
Intervention: Pegloticase (8 mg every 2 weeks or monthly)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pegloticase (monthly)
Number of subjects: 0
Study: 33231929

Group type: COMPARATOR
Intervention: Solifenacin (titrated doses of 2.5, 5, 7.5, or 10 mg/day)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194
Study: 34718252

Group type: EXPERIMENTAL
Intervention: rTMS two sessions per week
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: rTMS five sessions per week
Number of subjects: 91

Group type: COMPARATOR
Intervention: sham rTMS two sessions per week
Number of subjects: 91

Group type: COMPARATOR
Intervention: sham rTMS five sessions per week
Number of subjects: 91
Study: 32065831

Group type: EXPERIMENTAL
Intervention: Intravenous injection of 10 μg of IFN‐β‐1a once daily for 6 days
Number of subjects: 301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Intravenous injection of 10 μg of IFN‐β‐1a
Number of subjects: 301
Study: 36180115

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT) with a prescription dose of 30‐50 Gy in 3‐5 fractions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Androgen deprivation therapy (ADT) only
Number of subjects: 0
Study: 33711038

Group type: EXPERIMENTAL
Intervention: Facemask wearing (any type)
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Cloth facemasks
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: N95 facemasks
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Surgical facemasks
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Good knowledge about COVID-19
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Positive attitude towards precautions
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Belief in facemask effectiveness
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Discomfort wearing a facemask
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Government pressure to wear facemask
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Marital status
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Fear of the disease
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Belief in the effectiveness of a facemask
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Feeling government pressure
Number of subjects: 417
Study: 36283843

Group type: COMPARATOR
Intervention: Brief advice (10-minute phone-based psychoeducation plus feedback session)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Health coaching (two 45-minute sessions including education, feedback, motivational interviewing, and goal setting)
Number of subjects: 51
Study: 32423512

Group type: EXPERIMENTAL
Intervention: Dasotraline 6 mg/d
Number of subjects: 485

Group type: EXPERIMENTAL
Intervention: Dasotraline 4 mg/d
Number of subjects: 485

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 485
Study: 32808234

Group type: EXPERIMENTAL
Intervention: Dejian mind‐body intervention (DMBI)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study: 35411554

Group type: EXPERIMENTAL
Intervention: Sigmoidoscopy
Number of subjects: 140000

Group type: EXPERIMENTAL
Intervention: FIT
Number of subjects: 140000

Group type: EXPERIMENTAL
Intervention: Sigmoidoscopy and FIT
Number of subjects: 140000
Study: 33433246

Group type: EXPERIMENTAL
Intervention: Integra with NPWT
Number of subjects: 36

Group type: COMPARATOR
Intervention: Integra with partial packing compression dressings (control)
Number of subjects: 36
Study: 36226541

Group type: EXPERIMENTAL
Intervention: Vagus Nerve Stimulation (VNS) paired with rehabilitation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation paired with rehabilitation (Control)
Number of subjects: 0
Study: 33025749

Group type: EXPERIMENTAL
Intervention: Moses 2.0
Number of subjects: 27

Group type: COMPARATOR
Intervention: non-Moses
Number of subjects: 27
Study: 33243587

Group type: EXPERIMENTAL
Intervention: Extended depth-of-focus (EDOF) contact lens
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional multifocal (Biofinity MF) contact lens
Number of subjects: 30
Study: 32100275

Group type: EXPERIMENTAL
Intervention: Combined-ABT (linzagolix 200 mg/ABT for 10 weeks)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Delayed-ABT (linzagolix 200 mg for 4 weeks followed by linzagolix 200 mg/ABT for 6 weeks)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Linzagolix alone
Number of subjects: 32
Study: 35616653

Group type: EXPERIMENTAL
Intervention: Habit formation treatment delivered face to face during 12 weekly home‐based sessions (45 min each)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Habit formation (mechanism of change) assessed in treatment group only
Number of subjects: 30
Study: 33508159

Group type: EXPERIMENTAL
Intervention: 1064-nm Q-switched Nd:YAG laser treatment
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (untreated side)
Number of subjects: 19
Study: 32912977

Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal (CR) training, task-based training to downregulate negative affect, 4 sessions over 2 weeks.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control training, picture viewing, 4 sessions over 2 weeks.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal (CR) training
Number of subjects: 0
Study: 34130581

Group type: EXPERIMENTAL
Intervention: Fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion
Number of subjects: 0
Study: 33844890

Group type: EXPERIMENTAL
Intervention: Montelukast 4 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 35714174

Group type: EXPERIMENTAL
Intervention: 5 mg iv morphine
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 29
Study: 34270615

Group type: EXPERIMENTAL
Intervention: Reflective training on patient-centred communication
Number of subjects: 1120

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 1120
Study: 33832885

Group type: EXPERIMENTAL
Intervention: Obesecure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plasicure
Number of subjects: 0
Study: 36209091

Group type: EXPERIMENTAL
Intervention: Crocin (15 mg/day) for 90 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo for 90 days
Number of subjects: 40
Study: 32443963

Group type: EXPERIMENTAL
Intervention: Exergaming (EG)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Traditional multicomponent training (MG)
Number of subjects: 66
Study: 35927637

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (2000 IU per day for six weeks)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (lactose placebo)
Number of subjects: 22
Study: 32032566

Group type: EXPERIMENTAL
Intervention: PRIMVAC adjuvanted with GLA-SE (100 μg dose)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: PRIMVAC adjuvanted with Alhydrogel (100 μg dose)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: PRIMVAC/Alhydrogel
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: PRIMVAC/GLA-SE
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: PRIMVAC (100 μg dose and GLA-SE)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: PRIMVAC (100 μg dose)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: PRIMVAC (Alhydrogel or GLA-SE)
Number of subjects: 68
Study: 34384273

Group type: EXPERIMENTAL
Intervention: Multidisciplinary collaborative nursing intervention (MCNI)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Routine nursing procedure (Control)
Number of subjects: 84
Study: 32141373

Group type: EXPERIMENTAL
Intervention: In-home iPad lessons (8 weekly sessions)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 83
Study: 35347970

Group type: EXPERIMENTAL
Intervention: Individualized pragmatic randomized controlled trial (RCT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cluster RCT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single-case RCT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single arm RCT with objective performance criteria
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Partially nested RCT
Number of subjects: 0
Study: 34527611

Group type: EXPERIMENTAL
Intervention: 2 mg intravenous zoledronic acid
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 4 mg intravenous zoledronic acid
Number of subjects: 70

Group type: COMPARATOR
Intervention: 2 mg and 4 mg intravenous zoledronic acid
Number of subjects: 70
Study: 36446685

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided Seldinger method (n=55)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Open surgical cutdown method (n=56)
Number of subjects: 111
Study: 33524545

Group type: EXPERIMENTAL
Intervention: Neoadjuvant ADT for 6 months starting 4 months before prostate radiotherapy
Number of subjects: 393

Group type: COMPARATOR
Intervention: Adjuvant ADT for 6 months starting simultaneously with prostate radiotherapy
Number of subjects: 393